DENVER, Jan. 25, 2022 /PRNewswire/ — Akerna (Nasdaq: KERN), a leading enterprise software company and the developer of the most comprehensive technology infrastructure, ecosystem, and compliance engine powering the global cannabis industry, today announced the release of its annual Cannabis Industry Year-End Review.
You can access the report here.
This report highlights the state of the ever-changing and emerging cannabis industry. It takes a deep dive into capital markets, investing, new opportunities, data, consumer trends, marketing, eCommerce, and more.
Cannabis Industry Year-End Review Sections + Authors:
The report also includes information on 2021 data, current US federal reform efforts, legal cannabis states, the US Cannabis Council, and more.
“Despite its challenges, 2021 brought another year of growth in markets, consumers, and spending for the resilient cannabis industry,” said Jessica Billingsley, Akerna Chief Executive Officer. “I knew cannabis would never reach mass legalization and wide consumer adoption until it could be tracked and traced transparently and safely, and I am thrilled that Akerna’s ecosystem of software has provided that supply chain tracking need for our vibrant and growing industry.”
About Akerna:
Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna was the first cannabis software company listed on Nasdaq. The company’s cornerstone technology, MJ Platform, the world’s leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators.
For more information, visit https://www.akerna.com/.
Forward-Looking Statements:
LEGAL DISCLAIMERS: Certain statements made in this year-end review are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, as amended. When used in this mid-year review, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding: the future state of the cannabis marketplace, the key drivers for future cannabis markets, the potential benefits of Akerna Connect for brands and retailers, potential federal cannabis legislation in 2022, and other similar statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside Akerna’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include (i) Akerna’s ability to maintain relationships with customers and suppliers and retain its management and key employees, (ii) changes in applicable laws or regulations, (iii) changes in the market place due to the coronavirus pandemic or other market factors, (iv) risks related to our ability to successfully integrate our acquisitions and implement potential business opportunities, and (iv) and other risks and uncertainties disclosed from time to time in Akerna’s filings with the U.S. Securities and Exchange Commission, including those under “Risk Factors” therein. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein, except as required by law. Forecasts and estimates regarding Akerna’s industry and end markets are based on sources believed to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
View original content to download multimedia:https://www.prnewswire.com/news-releases/akerna-releases-2021-cannabis-industry-year-end-review-301467506.html
SOURCE Akerna
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…